Deutetrabenazine: A Review in Chorea Associated with Huntington’s Disease
Sign Up to like & getrecommendations! Published in 2017 at "Drugs"
DOI: 10.1007/s40265-017-0831-0
Abstract: Oral deutetrabenazine (Austedo™), a reversible inhibitor of vesicular monoamine transporter type 2 (VMAT2) that is structurally related to tetrabenazine is approved for the treatment of chorea symptoms associated with Huntington’s disease (HD). In the pivotal… read more here.
Keywords: tetrabenazine; associated huntington; huntington disease; deutetrabenazine ... See more keywords